RTOG 0436, A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer Who are Treated Without Surgery
December 23, 2009
Cancer - Gastro/ Esophageal
Principal Investigator: Eleanor M Walker, MD
The purpose of this study is to compare the effects, good and/or bad, of radiation therapy and chemotherapy (paclitaxel and cisplatin) with or without the addition of cetuximab to find out which treatment is better.
Patients must be between 18 and 75 years of age; Must not have had prior chemotherapy for your esophageal cancer; Participant should not have had prior radiation therapy that would result in overlap of planned radiation therapy fields.